Current approach to suspected typhoid (enteric fever)
The most actionable current guidance is the
CDC Yellow Book clinical guidance, with the
IDSA infectious-diarrhea guideline supporting the initial diagnostic and empiric-treatment steps. Antibiotic selection must be individualized by a clinician based on
where infection was likely acquired, illness severity, age, pregnancy status, allergies, and local resistance data.
1. Obtain microbiology urgently
- Take blood cultures before antibiotics whenever feasible, but do not delay treatment in a critically ill or septic patient.
- Obtain more than one blood culture if initial culture is negative and suspicion remains.
- Request organism identification and antimicrobial susceptibility testing.
- Stool and urine cultures can add information, but are less sensitive early in illness.
- Bone-marrow culture is more sensitive, especially after prior antibiotics, but is invasive and reserved for selected cases.
- Do not rely on Widal testing to diagnose typhoid because of poor specificity and false positives. CDC clinical guidance
2. Assess severity and admit if indicated
Urgent hospital assessment is appropriate with sepsis, confusion/encephalopathy, shock or dehydration, persistent vomiting, gastrointestinal bleeding, severe abdominal pain or distension, suspected intestinal perforation, or inability to take oral medication.
In people with suspected enteric fever and clinical sepsis, IDSA recommends drawing blood, stool, and urine cultures and then starting broad-spectrum empiric therapy, followed by narrowing treatment once susceptibilities return.
IDSA recommendation
3. Current empiric antibiotic principles
Do not use ciprofloxacin or another fluoroquinolone empirically in many settings, especially after travel to South Asia, because nonsusceptibility is common.
CDC's current travel-based approach:
| Likely acquisition / clinical status | CDC empiric approach while culture is pending |
|---|
| Uncomplicated illness after travel to Pakistan or Iraq, or illness acquired domestically in the United States | Azithromycin is the suggested empiric option |
| Complicated or severe illness after travel to Pakistan or Iraq, or domestically acquired U.S. illness | A carbapenem is suggested, typically in hospital care |
| Travel from most other countries | Ceftriaxone or azithromycin are appropriate empiric options |
| Culture-confirmed infection | Change to the narrowest effective antibiotic guided by susceptibility testing |
This is a clinician-directed framework, not a prescription. Ceftriaxone resistance has been reported in travelers from Iraq, India, and Afghanistan, and azithromycin resistance has been reported in several regions. The treatment choice can therefore differ substantially by location and by the culture result.
CDC Yellow Book treatment section
4. Supportive and public-health measures
- Oral or IV fluids and electrolyte correction as needed.
- Acetaminophen/paracetamol for fever if appropriate.
- Strict hand hygiene and no food preparation for other people while ill.
- Notify public health authorities according to local rules after confirmed infection. This is mandatory in many jurisdictions.
- Monitor for relapse, which can occur 1-3 weeks after apparent recovery, and for chronic carriage.
Why culture-guided therapy matters
Extensively drug-resistant (XDR)
S. Typhi may be resistant to ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole, fluoroquinolones, and ceftriaxone. That is why self-treatment or using leftover antibiotics is unsafe. WHO also advises treatment according to susceptibility testing and locally recognized resistance patterns.
WHO typhoid standard
A recent systematic review found azithromycin had outcomes at least comparable to ceftriaxone in the included trials, but this does
not override local resistance data or severity-based treatment decisions:
Uzair et al., 2024, PMID 39623850. Recent resistance evidence also reinforces the need for culture-based selection:
systematic review and meta-analysis, 2026, PMID 41990105.
If this concerns you or someone currently febrile, arrange same-day in-person assessment for cultures and treatment selection, rather than starting antibiotics without evaluation.